Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
BioLite, Inc.
National Cancer Institute (NCI)
Bristol-Myers Squibb
Beijing Biotech
Genmab
Cantargia AB
Beijing Biotech
Radiopharm Theranostics, Ltd
Beijing Biotech